Raymond James Financial Services Advisors’s Gilead Sciences GILD Stock Holding History

Raymond James Financial Services Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-54,100	Closed	-$25K	–	3326
2022 Q1	$25K	Buy	54,100 +18,400	+52%	+$1.18M	﹤0.01%	3247
2021 Q4	$53K	Hold	35,700	–	–	﹤0.01%	3183
2021 Q3	$100K	Buy	35,700 +2,000	+6%	+$141K	﹤0.01%	3117
2021 Q2	$98K	Buy	+33,700	New	+$2.25M	﹤0.01%	3140
2018 Q2	–	Sell	-39,800	Closed	-$4K	–	2811
2018 Q1	$4K	Buy	39,800 +5,800	+17%	+$461K	﹤0.01%	2539
2017 Q4	$14K	Buy	34,000 +10,100	+42%	+$767K	﹤0.01%	2509
2017 Q3	$18K	Buy	23,900 +13,600	+132%	+$1.04M	﹤0.01%	2514
2017 Q2	$38K	Buy	+10,300	New	+$685K	﹤0.01%	2431
2016 Q3	–	Sell	-16,900	Closed	-$3K	–	2334
2016 Q2	$3K	Sell	16,900 -1,800	-10%	-$160K	﹤0.01%	2276
2016 Q1	$15K	Buy	+18,700	New	+$1.69M	﹤0.01%	2030

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Raymond James Financial Services Advisors's GILD Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Gilead Sciences (GILD) stake by 5.6% in Q3 2024, selling an estimated $1.14M and leaving 252,749 shares worth $21.2M. The position accounts for 0.03% of the portfolio, ranked #528.

Raymond James Financial Services Advisors first reported a position in GILD in Q2 2013 and has held it in 43 quarters since. The position peaked at $34.9M in Q1 2020. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Raymond James Financial Services Advisors held 252,749 shares of Gilead Sciences worth $21.2M as of Q3 2024.
Raymond James Financial Services Advisors sold 14,974 Gilead Sciences shares in Q3 2024, an estimated $1.14M.
Gilead Sciences made up 0.03% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #528 holding.
Raymond James Financial Services Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 43 quarters since.
Raymond James Financial Services Advisors's Gilead Sciences position peaked at $34.9M in Q1 2020.
1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.